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The changes in retinal thickness and visual function in type 2 diabetic patients without clinical evidence of diabetic retinopathy 
were evaluated. A total of 141 diabetic subjects without retinopathy and 158 healthy subjects were enrolled in this study. Supe-
rior macular ganglion cell complex thicknesses were significantly decreased in diabetic cases, and no significant peripapillary 
retinal nerve fiber layer thickness changes were observed. The contrast sensitivities at all space frequencies were significantly 
different between diabetic patients and controls. The mean P50 amplitude from pattern electroretinogram results was reduced 
significantly in the diabetic group. In the diabetic group, average superior ganglion cell complex thicknesses positively corre-
lated with both contrast sensitivities at high spatial frequencies and P50 amplitudes. The results indicated that ganglion cell 
complex thickness and visual function changes could be observed in diabetic subjects before the onset of any significant dia-
betic retinopathy. Macular ganglion cell complex reduction occurred much earlier than peripapillary retinal nerve fiber layer 
thinning in diabetic patients without retinopathy. 
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Diabetic retinopathy (DR) is one of the major complications 
in patients with diabetes mellitus (DM) that can lead to 
blindness. DR has been considered primarily a retinal mi-
crovascular disorder caused by the direct effects of hyper-
glycemia and by the metabolic pathways it activates [1]. 
Previous studies have shown that vascular abnormalities 
and neuronal alterations, including neural apoptosis, loss of 
ganglion cells, glial reactivity, and reduction in thickness of 
the inner retinal layers, accompany the pathogenic changes 
at the earliest stages of DR [25]. Moreover, structural 
neuropathy can occur prior to the onset of visible diabetic 
vasculopathy, as shown in earlier experimental studies [5,6]. 
Structural alterations of retinal nerve tissue have also been 
reported in several clinical studies, as evidenced by thinning 
of the retinal nerve fiber layer (RNFL) in diabetic patients 
without diabetic retinopathy (NDR) compared with non- 
diabetic patients [79]. 
In addition to typical retinopathies, neurovisual impair-
ments have been reported. Abnormalities in visual evoked 
potentials, contrast sensitivity, and dark adaption and elec-
troretinogram (ERG) scans have been assessed in diabetic 
patients and indicated neuronal system involvement 
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[2,1014]. Morphological changes of retinal nerve tissue 
may explain the neurovisual functional deficits that are ob-
served in diabetic patients, even before the overt retinopathy 
is seen. However, to the best of our knowledge, relation-
ships between early retinal structure alterations and visual 
function impairments in a same population of NDR have 
not been reported. The purpose of our study was to evaluate 
the hypothesis that RNFL thickness and ganglion cell com-
plex (GCC) thickness measured by spectral domain optical 
coherence tomography (SD OCT) and the visual functions 
tested with contrast sensitivity and pattern ERG (PERG) 
were associated in NDR patients. 
1  Materials and methods 
1.1  Study participants 
This was a cross-sectional, case-control study. Patients were 
randomly recruited from the outpatient clinic of the 
Zhongshan Ophthalmic Center (Sun Yat-Sen University, 
Guangzhou). Inclusion criteria were type 2 DM patients 
without any signs of DR as evaluated by a retinal specialist 
(J Ma) through indirect fundoscopy and stereo color fundus 
photography, according to the International Clinical Dia-
betic Retinopathy Disease Severity Scale [15]. Exclusion 
criteria were clinically observed DR, myopia more than six 
diopters, visual acuity below 0.1, intraocular pressure (IOP) 
higher than 21 mmHg, history of glaucoma, uveitis, or reti-
nal disease, or previous history of laser or intraocular sur-
gery. Age- and sex-matched subjects, free of ocular disease, 
diabetes, hypertension, or other systemic diseases were re-
cruited as controls from among those who accompanied 
patients visiting the outpatient clinic. The study was ap-
proved by the Zhongshan Ophthalmic Center institutional 
review board and conformed to the tenets of the Declaration 
of Helsinki, and all participants gave written informed con-
sent. 
Each subject underwent a complete ophthalmic examina-
tion, including determining best-corrected visual acuity 
(BCVA), refraction measurement, IOP measurement by 
noncontact tonometry, slit-lamp biomicroscopy, and dilated 
fundus examinations. All subjects were divided into two 
study groups, the NDR and control group, and NDR was 
defined as the absence of all features of DR [15]. 
1.2  SD OCT measurements 
OCT was performed to obtain measurements of the peri-
papillary RNFL thickness using the RTVue-100 device 
(Optovue, Inc., Fremont, CA, USA). One eye of each sub-
ject was randomly chosen for measurement, and every eye 
was repeatedly measured three times. The peripapillary 
thickness was determined by optical nerve head mode, in 
which data along a 3.4-mm diameter circle around the optic 
disc were recalculated with a map created from en face im-
aging, using six circular and 12 linear data inputs. Average, 
superior, and inferior RNFL thicknesses were calculated. 
The GCC parameters were obtained by the macular map 
protocol, centered 1 mm temporal to the fovea. This proto-
col used one horizontal line with a 7-mm scan length (934 
A-scans), followed by 15 vertical lines with a 7-mm scan 
length and 0.5-mm interval (800 A-scans). The GCC thick-
ness was measured from the internal limiting membrane to 
the inner plexiform layer boundary; average, superior, and 
inferior GCC thicknesses were calculated. 
1.3  Contrast sensitivity test 
Contrast sensitivity was evaluated with the OPTC 6500 
(Stereo Optical; Chicago, IL, USA). This test provided 
presentation of sine-wave gratings of different spatial fre-
quencies (1.5, 3, 6, 12, and 18 cycles per degree (cpd)) with 
a contrast-level change step corresponding to 0.15 log con-
trast sensitivity. Following the manufacturer’s protocol, the 
testing distance was 3 m for distance. The optimum addi-
tional spectacle corrections were used and an evaluation  
of the contrast sensitivity test was done monocularly in  
each subject. The contrast sensitivity measurements    
were performed under a constant luminance condition of 
85.0 cd m2.  
1.4  PERG 
PERG was performed according to the International Society 
for Clinical Electrophysiology of Vision standard for clini-
cal patterns [16]. In brief, gold foil corneal recording elec-
trodes were positioned directly under the center of the pupil 
so that there was no movement of the electrode when the 
patient blinked. Reference and ground electrodes were 
placed in the outer canthus and on the forehead, respectively. 
A black-and-white reverse checkerboard pattern was used 
with an aspect ratio of width over height of the stimulus 
field not exceeding 4:3. The mean of the width and height 
of the stimulus field was 15 degrees, with a check size of 
0.8 degrees. The contrast between black and white squares 
was close to 100%. The reversal rate was 2.2 Hz. A mini-
mum of 100 artifact-free sweeps was collected and averaged. 
The P50 amplitude was calculated from the trough of N35 
to the peak of P50. All data were recorded without pupil 
dilation. 
1.5  Data analyses 
Descriptive statistical data were described as the mean with 
standard deviation. All statistical analyses were performed 
using SPSS software version 17.0 (SPSS Co., Chicago, IL, 
USA). The distributions of characteristic data such as age, 
sex, and IOP in two groups were checked by using χ2 tests 
or unpaired t-tests, as appropriate. For the statistical com-
parison of RNFL thickness and GCC thickness between two 
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groups, the ANOVA analysis was used. Correlation anal-
yses were performed using Pearson’s correlation coefficient 
for parametric data. P values less than 0.05 were considered 
as statistically significant. 
2  Results 
2.1  General characteristics 
A total of 141 eyes from 141 NDR subjects and 158 eyes 
from 158 healthy subjects met our criteria and were includ-
ed in this study. The characteristics of the two groups are 
presented in Table 1. No significant difference was found 
for age, sex, and IOP among groups. 
2.2  Peripapillary RNFL and macular GCC thickness 
After adjusting for age and gender, the average, superior 
and inferior peripapillary RNFL thicknesses were 102.0± 
12.1 μm, 128.5±15.3 μm, and 124.1±14.9 μm in controls, 
respectively, and 99.2±14.7 μm, 126.0±16.1 μm, and 
120.0±15.3 μm in NDR subjects, respectively. The average, 
superior and inferior macular GCC thicknesses were 
101.6±10.2 μm, 111.3±11.1 μm, and 110.2±10.2 μm in 
controls, respectively, and 99.3±9.5 μm, 103.2±13.2 μm, 
and 106.0±11.3 μm in NDR subjects, respectively. Differ-
ences in all RNFL parameters between NDR and control 
eyes were not statistically significant. The macular GCC 
thickness in the NDR eyes was significantly reduced     
by 6.8% in the superior region (ANOVA, P<0.05), whereas 
no significant difference was found in the inferior area 
(Figure 1). 
2.3  Visual function 
Table 2 shows visual function parameters in the two groups, 
including BCVA, contrast sensitivity values, P50 implicit 
times, and amplitudes from PERG. According to Table 2, 
all data showed normal distributions upon Kolmogorov- 
Smirnov normality testing. There was no significant differ-
ence in BCVA among the control and NDR groups. Con-
trast sensitivity values were significantly decreased at every 
spatial frequency in the NDR versus control groups  
Table 1  Clincal characteristics of normal and NDR subjectsa) 
Characteristics Normal NDR P value
Case number 158 141 
Male sex, n (%) 86 (54.4) 76 (53.9) 0.91 
Age (year), mean±SD 63.62±10.57 68.10±9.33 0.38 
IOP (mmHg), mean±SD 16.05±2.25 14.53±2.50 0.22 
Diabetes duration (year)  9.75±2.11 
a) NDR, no diabetic retinopathy; IOP, intraocular pressure. Age and 
IOP were analyzed by t test, male sex was analyzed by Chi-square test. 
 
Figure 1  Peripapillary retinal nerve fiber layer (RNFL) thickness (A) and 
macular ganglion cell complex (GCC) thickness (B) measured by spec-
tral-domain optic coherence tomography in diabetic patients without dia-
betic retinopathy (NDR) and in normal subjects. The asterisk indicates 
statistically different changes. 
(ANOVA, all P<0.05). Results of PERG showed that the 
P50 amplitudes were significantly different between groups 
(ANOVA, P<0.05), whereas the P50 implicit time was not 
changed significantly. 
2.4  Correlations 
In NDR eyes, significant positive correlations were found 
between superior macular GCC and contrast sensitivity at 
spatial frequencies of 6, 12, 18 cpd (r=0.51, 0.52, and 0.49, 
respectively; all P<0.05), and lower positive correlations 
were also found between inferior RNFL and contrast sensi-
tivity at high spatial frequencies of 12 and 18 cpd (r=0.3 
and 0.25, respectively; P<0.05). For the PERG data, there 
were positive correlations between P50 amplitudes and both 
inferior RNFL thickness and superior GCC thickness 
(r=0.65 and 0.41, respectively; both P<0.05). Interestingly, 
no significant correlation was found between P50 implicit 
times and any retinal structure parameter (Table 3). 
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Contrast sensitivity PERG 
1.5 cpd 3 cpd 6 cpd 12 cpd 18 cpd Amplitude (μm) Implicit time (ms) 
NDR 0.10±0.19 37.78±11.06 49.02±10.81 61.21±15.09 30.22±4.73 10.19±1.26 0.91±0.16 63.29±8.15 
Normal 0.08±0.11 49.01±10.77 64.11±13.08 79.33±16.21 45.5±8.70 17.55±2.62 1.42±0.20 61.11±8.39 
P value* 0.82 0.03 0.04 0.01 0.01 0.02 0.02 0.15 
a) NDR, no diabetic retinopathy; BCVA, best corrected visual acuity; cpd, cycles per degree; pERG, pattern electroretinogram. Data are reported as 
mean±SD. Bold font indicates significant difference between NDR and normal groups. *, ANOVA analysis. 
Table 3  Correlations between retinal neural thicknesses and visual function parameters in NDR subjectsa) 
Parameters  
Contrast sensitivity PERG 
1.5 cpd 3 cpd 6 cpd 12 cpd 18 cpd Amplitude (μm) Implicit time (ms) 
Average RNFL r 0.19 0.13 0.11 0.16 0.34 0.11 0.29 
P value 0.18 0.25 0.32 0.25 0.13 0.23 0.11 
Superior RNFL r 0.16 0.07 0.13 0.14 0.17 0.19 0.22 
P value 0.15 0.51 0.32 0.22 0.17 0.09 0.09 
Inferior RNFL r 0.12 0.19 0.22 0.3 0.25 0.65 0.19 
P value 0.33 0.28 0.09 0.01 0.04 0.01 0.09 
Average GCC r 0.13 0.14 0.19 0.22 0.17 0.16 0.07 
P value 0.32 0.22 0.09 0.09 0.17 0.15 0.51 
Superior GCC r 0.2 0.24 0.51 0.52 0.49 0.41 0.32 
P value 0.13 0.11 0.01 0.01 0.01 0.04 0.07 
Inferior GCC r 0.12 0.13 0.24 0.19 0.32 0.19 0.2 
P value 0.33 0.32 0.11 0.13 0.07 0.09 0.11 
a) NDR, no diabetic retinopathy; BCVA, best corrected visual acuity; cpd, cycles per degree; pERG, pattern electroretinogram. Data are reported as 
mean±SD. Bold font indicates significant correlation. 
3  Discussion 
In this study we demonstrated that macular GCC thickness 
was significantly correlated with visual function parameters, 
such as contrast sensitivity and PERG amplitudes, in NDR 
patients compared with control subjects. To our knowledge, 
this is the first study exploring the structure-function rela-
tionships of the retina in diabetic patients before the onset of 
DR. 
Previous work suggested that early neuronal degenera-
tion in the retina could occur even though the retinal vascu-
lar lesions in diabetic patients were minimal. The inner ret-
ina, which is supplied by the retinal vessels, seems to be 
more vulnerable to metabolic stress induced by diabetes, 
compared with the outer retina, which is supplied by the 
choroidal circulatory system [17]. Therefore, in our study 
the peripapillary RNFL and macular GCC thicknesses were 
measured by SD OCT to detect early neuronal degeneration. 
It is well known that RNFL and GCC thicknesses decreased 
with age [18,19]. As shown in Table 1, there was no signif-
icant difference with respect to age between diabetic and 
normal subjects. Moreover, to exclude the possibility that 
retinal inner layer thickness was decreased with age, in this 
study we adjusted the ages within the study groups. 
In the present study, we did not find significant differ-
ences in peripapillary RNFL thicknesses between the NDR 
and normal groups, although there was a trend of sectional 
RNFL reduction in NDR patients versus controls. This 
finding was consistent with other studies of preclinical DR 
[2022]. One possible reason may be the high density of 
retinal nerve fibers in the peripapillary region [22]. Howev-
er, significant thinning of the peripapillary RNFL thickness 
in preclinical DR has been reported in some previous stud-
ies [8,23,24]. This discrepancy between studies may be due 
to the difference in patient populations, devices for RNFL 
measurements, or study designs. It has been suggested that 
the peripapillary RNFL thickness profiles measured with 
OCT vary among individuals, and this variation was large 
relative to other factors, such as measurement error [25,26], 
optic disc size [27], or the retinal arterioles and venules ex-
tending from the optic disc [28]. 
In addition to peripapillary RNFL, we also evaluated 
macular GCC thickness to detect inner retinal damage. The 
macular region may be more susceptible to diabetic damage, 
because of its higher metabolic demands when compared 
with the peripapillary region [22]. The GCC thickness 
measured in the present study consisted of the macular 
RNFL, ganglion cell layer and inner plexiform layer. As 
reported by Kim et al. [29], the GCC thickness was a more 
direct measure of the integrity of retinal ganglion cells, and 
could be considered a better indicator of early retinal neu-
ronal damage than peripapillary RNFL. Although the peri-
papillary RNFL thickness was not changed in the NDR 
group, in this study we observed a significant decrease of up 
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to 6.8% in superior macular GCC thickness in NDR patients 
compared with controls. Similar results have been reported 
previously [8,30,31]. Our finding of macular GCC loss 
could be explained by the loss of retinal ganglion cells and 
axons prior to the thinning of the RNFL [32,33]. In addition, 
the superior region of the macular is more susceptible to 
initial diabetic damage than the other regions. A previous 
diabetic animal model study reported that the superior area 
had twice the number of microaneurysms and cellular ca-
pillaries compared with the inferior area in the retina [34], 
suggesting a different retinopathy in the superior versus 
inferior regions. However, further studies are needed to de-
termine the cause of the reduction in macular GCC thick-
ness in diabetic patients without clinical DR. 
The BCVA did not differ between NDR and normal 
groups in the present study. We hypothesize that the slight 
macular GCC loss in NDR patients may be insufficient to 
detect significant BCVA changes. Previous contrast sensi-
tivity tests revealed abnormal functions before visual acuity 
tests, and correlated positively with the presence and the 
degree of diabetic retinopathy [35]. Several contrast sensi-
tivity studies in diabetic patients showed a general decrease 
of sensitivity across low, medium, and high spatial frequen-
cies, suggesting that both the parvocellular and magnocel-
lular systems involved in contrast processing were affected 
by the disease [12,3537]. Similar results were found in our 
study, where contrast sensitivities at each spatial frequency 
(from 1.5 to 18 cpd) were significantly decreased in NDR 
patients, compared with normal subjects. It has been sug-
gested that the contrast abnormality occurring before the 
onset of the DR may be due to early retinal neural degener-
ation [3739]. Interestingly, in our study we found that only 
contrast sensitivities at high spatial frequencies were posi-
tively correlated with macular GCC and peripapillary RNFL 
thickness. These correlations are expected because previous 
studies indicated that the selective losses at high spatial 
frequencies may be due to the dysfunction in the parvocel-
lular pathway [35,37], and approximately 80% of ganglion 
cells are parvocellular cells [40].  
The PERG is a mass potential that sums information 
primarily from the electrical potential of retinal ganglion 
cells [41,42]. It was suggested that the PERG response 
measured retinal ganglion cell activity; therefore, the direct 
loss of ganglion cell counts may affect the PERG response. 
In the present study, we also found a significant PERG am-
plitude reduction in NDR patients, which correlated with 
decreased superior macular GCC thickness. These results 
support the theory that the PERG relied on a centrally pre-
sented stimulus, in particular GCC thickness, and was 
strongly associated with macular parameters. However, the 
significant association between PERG amplitude and peri-
papillary inferior RNFL thickness in the NDR group also 
suggested that the PERG was measuring more than a central 
response [43]. For PERG implicit times, we did not observe 
any significant change or correlation with retinal inner layer 
thickness. A previous study suggested that a delay in ERG 
implicit times correlated with the chance of onset and de-
velopment of DR [44]. Thus, there was a slight increase in 
implicit times in the NDR group, which was not significant, 
because in this study we only evaluated diabetic patients 
without DR. 
There are several limitations of the present study. First, 
the sample size was small, although significant GCC 
changes were measured in NDR patients. Second, most of 
the diabetic patients we included in this study had con-
trolled blood glucose levels, and some were receiving insu-
lin therapy. It has been suggested that insulin can reverse 
retinal apoptosis and provide trophic support for retinal 
neurons [45]. The changes in GCC and RNFL thicknesses 
between NDR patients and control subjects may be larger 
because untreated diabetics were not included. Furthermore, 
the SD OCT could not provide a sectorial analysis of macu-
lar GCC; therefore we evaluated only the more limited data 
of GCC (average, superior, and inferior GCC thickness). If 
subdivided macular GCC data were available, the results 
could be more conclusive. 
In summary, our results provided proof of concept that 
early neuronal degeneration existed in the inner retina in 
diabetic patients before the onset of clinical DR. SD OCT 
demonstrated that macular GCC thickness decreased much 
earlier than peripapillary RNFL thinning. In addition, cor-
relations between GCC thicknesses and contrast sensitivities 
in NDR patients suggested that a loss of parvocellular cells 
may be involved in macular GCC damage. However, 
whether the macular GCC changes in diabetic eyes were a 
result of the effect of vascular diabetic retinopathy or 
whether they were primarily caused by direct neurological 
damage from chronic hyperglycemia requires further study. 
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